CJC-1295 No DAC (5mg) + Ipamorelin (10mg)
$291.92
CJC-1295 No DAC (5mg) + Ipamorelin (10mg) Peptide Pen is an advanced dual-peptide research formulation widely studied for its role in growth hormone signaling, recovery pathways, sleep-related GH pulsatility, and body composition research.
20
People watching this product now!
Research Purpose
- Studied for its potential role in stimulating pulsatile growth hormone release through combined GHRH and ghrelin receptor activation.
- Investigated in laboratory research involving IGF-1 regulation and endocrine signaling.
- Commonly used in studies of metabolism, body composition, and growth hormone secretagogue activity.
- Explored for the synergistic effects of CJC-1295 No DAC and Ipamorelin on growth hormone signaling pathways.
Ingredients
- Active Compound 1: CJC-1295 No DAC (Mod GRF 1-29) – 5mg
- Active Compound 2: Ipamorelin – 10mg
- Total Strength: 15mg
- Purity: ≥99% (HPLC Tested)
- Form: Lyophilised Powder
Packaging Contents
- 1 × Sterile vial containing CJC-1295 No DAC 5mg + Ipamorelin 10mg
- Tamper-evident protective cap
- Lyophilised powder for laboratory reconstitution
- Secure protective packaging
Molecular Structure
CJC-1295 No DAC (Mod GRF 1-29)
- Chemical Classification: Synthetic Growth Hormone-Releasing Hormone (GHRH) analogue
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Molecular Weight: 3,364.9 g/mol
Ipamorelin
- Chemical Classification: Synthetic Growth Hormone Secretagogue (GHS)
- Peptide Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
- Molecular Formula: C₃₈H₄₉N₉O₅
- Molecular Weight: 711.85 g/mol
Related products
Semax 15mg
Semax 15MG Peptide Pen is a synthetic heptapeptide studied in research environments for its interaction with neurotrophic and neurotransmitter signaling pathways related to cognitive function, attention regulation, and neuroprotection mechanisms. Supplied in a ready-to-use peptide pen format for laboratory research use only.
